Literature DB >> 8003899

[Therapeutic approach in Mycobacterium ulcerans infections].

H Darie1, S Djakeaux, A Cautoclaud.   

Abstract

In Côte d'Ivoire, 88 patients of a series of 124 cases with Buruli ulcer have been able to be treated and supervised. All of them have received local cares and various antibiotics, and 23 have been treated by islet skin graft. Among the numerous antibiotics used, only Streptomycin seems to be accompanied by an acceptable failure rate. The islet-graft presents the advantage of the technical simplicity, of the good tolerance face the infection and of a good successful rate, which permits to shorten the evolution of this disabling affection. It seems to be the best adapted procedure taking into account available medical means in most of tropical countries.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003899

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot        ISSN: 0037-9085


  4 in total

1.  Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.

Authors:  A Bentoucha; J Robert; H Dega; N Lounis; V Jarlier; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

2.  Aquatic plants stimulate the growth of and biofilm formation by Mycobacterium ulcerans in axenic culture and harbor these bacteria in the environment.

Authors:  Laurent Marsollier; Timothy Stinear; Jacques Aubry; Jean Paul Saint André; Raymond Robert; Pierre Legras; Anne-Lise Manceau; Christine Audrain; Sandra Bourdon; Henri Kouakou; Bernard Carbonnelle
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

3.  Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice.

Authors:  Laurent Marsollier; Nadine Honoré; Pierre Legras; Anne Lise Manceau; Henri Kouakou; Bernard Carbonnelle; Stewart T Cole
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 4.  Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).

Authors:  Rie R Yotsu; Marty Richardson; Norihisa Ishii
Journal:  Cochrane Database Syst Rev       Date:  2018-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.